A meta‐analysis, including seven studies and 695 patients, demonstrated that for patients with LA‐NSCLC treated with definitive CRT, no significant difference in the ORR between patients with or without EGFR mutations was noted; however, patients with EGFR mutation had a significantly lower rate of local recurrence and a higher rate of BM.31 Here, EGFR is linked to non-small cell lung carcinoma.